- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP
- Report
- November 2022
- 286 Pages
Global
From €2495EUR$2,625USD£2,096GBP
€4991EUR$5,250USD£4,193GBP
- Book
- May 2025
North America
- Book
- July 2020
North America
- Book
- August 2019
North America
- Book
- December 2018
North America
- Book
- October 2018
- 376 Pages

The Immune Deficiencies market is a subset of the Allergy and Immunology field, focusing on the diagnosis and treatment of disorders that affect the body's ability to fight off infection. These disorders can be caused by genetic mutations, environmental factors, or a combination of both. Common treatments include antibiotics, immunoglobulin replacement therapy, and stem cell transplants. In some cases, lifestyle changes such as dietary modifications and stress management can also be beneficial.
The Immune Deficiencies market is a rapidly growing field, with new treatments and technologies being developed to improve patient outcomes. Companies in this market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more